Skip to main navigation Skip to search Skip to main content

RBM15-MKL1 (OTT-MAL) fusion transcript in an adult acute myeloid leukemia patient

  • Hui Hua Hsiao
  • , Ming Yu Yang
  • , Yi Chang Liu
  • , Hui Pin Hsiao
  • , Shih Bin Tseng
  • , Mei Chyn Chao
  • , Ta Chih Liu
  • , Sheng Fung Lin*
  • *Corresponding author for this work
  • Kaohsiung Medical University

Research output: Contribution to journalReview articlepeer-review

22 Scopus citations

Abstract

The t(1;22)(p13;q13) is a nonrandom chromosomal abnormality in acute leukemia with the fusion oncogene, RBM15-MKL1 (OTT-MAL), identified recently. However, this abnormality has been described only in infants and young children with acute megakaryoblastic leukemia (AMKL). We report a 59-year-old male patient with the diagnosis of acute myeloid leukemia, subtype M1, who harbors an abnormal chromosome +der(1)t(1;22)(p13;q13). The RBM15-MKL1 (OTT-MAL) fusion transcript was also confirmed by the reverse transcriptase-polymerase chain reaction. This unusual abnormality is rare in adult cases of leukemia, and in children it is restricted to AMKL. This report is accompanied by a review of the literature on the t(1;22)(p13;q13).

Original languageEnglish
Pages (from-to)43-45
Number of pages3
JournalAmerican Journal of Hematology
Volume79
Issue number1
DOIs
StatePublished - 05 2005
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • AML
  • OTT-MAL
  • RBM15-MKL1
  • t(1;22)

Fingerprint

Dive into the research topics of 'RBM15-MKL1 (OTT-MAL) fusion transcript in an adult acute myeloid leukemia patient'. Together they form a unique fingerprint.

Cite this